Commentary on 'Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing' by Camell et al., Nature 2017. 8 Ageing is a major risk for all myocardial diseases and we are all carriers of this risk factor. Therefore, the senescent heart has been a focus of cardiovascular research for many years and much is already known about the final consequences of ageing: Morphologically, the heart displays higher levels of fibrosis, cardiomyocyte loss due to apoptosis and necrosis as well as hypertrophy of the remaining cardiomyocytes. 1 These structural changes worsen the outcome of almost all cardiac pathologies including atrial fibrillation and heart failure and potentially precipitate these two common disorders. Besides the increased arterial stiffness and higher systolic blood pressures leading to exhaustion of the ageing heart, a sterile autoimmune inflammation has been discovered to cause the structural changes. 2 Functionally, the senescent, but healthy heart performs well under baseline conditions but loses the ability to adapt to higher demands during exercise or stress. This becomes most obvious regarding the diminished ability to increase the heart rate and contractility, which can be explained by an attenuated reaction to adrenergic stimulation 3 due to an overall diminished functional response and less sensitivity to noradrenalin (NA). 4 Furthermore, the heart comprises lower amounts of NA in senescence, 5, 6 which to date was attributed to a net loss in NA releasing nerves. 7 Interestingly, a recent publication found a new mechanism leading to reduced NA levels in tissue during ageing. Camell and colleagues 8 reported that the well-known loss of the ability to burn fat in the senescent fat tissue can be explained by a gain of function of the macrophages Dr. Tobias Bruegmann is working group leader at the Institute of Physiology I at the University of Bonn and chairmen of the Young physiologists, the group for young scientists within the German Physiological Society. Dr Bruegmann graduated in medicine in Bonn (2012) and received his MD in 2013 for establishing optogenetic stimulation of the heart. Ever since, he focussed his work on applying this new method to address new questions in cardiac electrophysiology and to explore new treatment options such as optogenetic cardioversion and defibrillation. His PhD thesis was submitted in 2017 and he starts now to establish his own working group with the focus on optogenetic stimulation to study vegetative physiology and to explore the feasibility of new treatment options for possible clinical use in the future.
Prof. Godfrey L. Smith (PhD Glasgow 1982), has held research positions in the Departments of Biophysics, University of Texas Medical Branch, Galveston TX, and Physiology, University College London. He obtained a tenured academic position at the University of Glasgow in 1989 and was appointed Professor of Cardiovascular Physiology in 1998. He is currently deputy director of the Institute of Cardiovascular and Medical Sciences at Glasgow University and has served on several national and international committees, including the Physiological Society and the European Society of Cardiology (currently a council member and past-chair of the working group on Cellular Cardiac Electrophysiology). His research addresses the cardiac excitation-contraction process in health and disease including: mechanisms of contraction failure; small molecule modulators of Ca 2þ signalling; and arrhythmic mechanisms associated with ischaemic cardiomyopathy. His research uses a series of novel biophysical techniques including multiphoton microscopy. He is a cofounder and CSO of a spin-out company (Clyde Biosciences Ltd) centred on a medium through-put functional cardiotox assay using novel optical techniques. within the adipose tissue (ATM). In senescent ATM, activation of the NLRP3 pathway induces the expression of the enzyme monoamine oxidase A (MAOA) leading to degradation of NA. Thus the bioavailability of this neurotransmitter is reduced which is important for stress-induced lipolysis. Accordingly, fat tissue isolated from aged mice showed normal lipolysis when stimulated exogenously by supramaximal amounts of NA and aged mice retained their ability to burn fat after pharmacological inhibition of MAOA, or genetical knock out of the Nlrp3 -/-gene. The authors could also demonstrate a general ability of bone marrow derived macrophages to block NA induced lipolysis in fat explanted from young mice after activation of the macrophages' NLPR3 inflammasome. 8 However, the mechanism responsible for NA uptake in senescent ATM was not determined in this report. In fact it has been shown before that NA uptake mechanisms in macrophages from bone marrow/blood origin can be independent of common pathways that use norepinephrine transporters (NETs) or simple diffusion. 9 The general principle of NA degradation by macrophages in fat was also reported in adult fat tissue with relevance to obesity. Sympathetic neuron-associated macrophages (SAMs) surrounding the NA secreting nerves are able to take up NA by NET and degrade via MAOA. High fat diet has less detrimental effects when SAM are lacking NET and more NA is available within the fat tissue to stimulate lipolysis. 10 Importantly, also this paper found that the NAdegrading macrophages arise from the bone marrow/blood monocytes' pool. However, it is not clear whether both studies report uptake by the same mechanism and by the same subtype of macrophages or whether ageing does induce NA degradation in completely different macrophages, e.g. the ATM. Fat tissue and the heart share many similarities regarding adrenergic signalling and especially its diminished effects in senescence. Interestingly, the macrophages residing normally within the heart originate during embryogenesis from yolk sac and foetal monocyte progenitors but can be replaced by bone marrow derived blood monocytes' input after birth. 11 Although the total number of macrophages is declining during ageing, the number of bone marrow derived macrophages increases slightly 2 which could be a hint that they also functionally gain importance.
Very recently it has been discovered that b-adrenergic overstimulation attracts macrophages to the heart inducing cardiac fibrosis. 12 If macrophages could also degrade NA in the heart, this would suggest a negative feedback mechanism that could be enhanced in the senescent heart. In line with this, despite the lower amounts of NA in the aged heart, there are elevated catecholamine levels in blood of the elderly. Paradoxically, many studies found attenuated NA uptake within the senescent heart. 6, 13 However, so far research focussed only on the NA uptake1 via NET in the terminal nerve endings which plays the biggest role in the adult heart. 14 These experiments do not exclude an additional competing mechanism which gains importance with senescence. In this specific context, a functional role of macrophages in determining NA sensitivity in the heart during ageing has yet to be investigated. Only recently two heart-specific roles for macrophages in addition to the canonical phagocytosis have been proposed: (i) Monnerat et al. found that chronic hyperglycaemia forces cardiac macrophages to secrete Interleukin-1b causing changes in the electrophysiological behaviour of the cardiomyocytes which might be responsible for the high arrhythmia risk of diabetic patients. 15 Although this mechanism would represent an inflammatory connection between macrophages and cardiomyocytes in a pathologic situation, the second paper suggested a direct influence of macrophages on cardiac electrical properties.
(ii) Hulsmans and colleagues found a high amount of macrophages clustering around the lower part of the AV node directly coupled to the HCN4 expressing cells of the AV node through gap junctions built by connexine43. Through this direct coupling, the AV node cardiomyocytes become depolarized facilitating the electrical conduction to the ventricles. 16 However, both studies did not investigate the senescent heart and the question remains open to what extent cardiac macrophages or specific subtypes could degrade NA and be thus responsible for age-dependent modulation of functional responses to sympathetic stimulation. Taken together, there are good arguments to investigate whether such a mechanism exists in the heart and if so determine its role within the aged heart. Crucial experiments are therefore to detect NAdegrading macrophages within the heart and carefully characterize their origin and subtype. The process used by macrophages to take up and degrade NA is of particular interest; if this mechanism is distinct from NETs used by nerves, it could be modulated independently and offer a new treatment option. Finally, the cause for an age-associated gain of function of the NA uptake mechanisms has to be carefully resolved. Over all, the intriguing question is what is the leading cause of the reduced response to adrenergic stimulation in the aged human heart?
